Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | IMA950 |
Synonyms | |
Therapy Description |
IMA950 is a cancer vaccine consisting of 11 glioblastoma multiforme-associated peptides, which may lead to anti-tumor immune response (PMID: 28497804). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
IMA950 | IMA-950 | IMA950 is a cancer vaccine consisting of 11 glioblastoma multiforme-associated peptides, which may lead to anti-tumor immune response (PMID: 28497804). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|